ABSTRACT SUBMITTAL & PRESENTATION GUIDELINES - March 25-27, 2020 in New Orleans, Louisiana - 1Joshua Group ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
March 25–27, 2020 in New Orleans, Louisiana
ABSTRACT
SUBMITTAL &
PRESENTATION
GUIDELINES
ALL SUBMISSIONS DUE: 02/10/2020 @ 11:59 PM CENTRAL
#XUHDCON
ABSTR ACT SUBMISSION OVERVIEW
We are soliciting abstracts for oral and poster presentation. Abstracts from all
fields of biomedical research are encouraged. Abstracts presented at other meetings are allowed.
Selected abstracts will be presented during Concurrent Podium Presentation Sessions and/or
during Poster Sessions.
Abstracts will be accepted via electronic submission only. Abstracts that do not conform to official
guidelines will NOT be accepted.
Abstracts will not be considered unless submitted via the online form.
REGISTRATION: All presenting authors are required to register/pre-register for
the Conference. Payment is not required immediately at the time of registration, but
registration fees must be paid by the respective deadlines in order for discounts to
apply, and all registration balances must be paid in order to participate in the XULA 2018
Conference.
DEADLINE: All abstracts must be submitted via the online form no later than
11:59 PM Central on Monday, February 10, 2020. No corrections will be allowed.
TARGET AREAS: All abstracts should represent basic science, clinical science,
community populations and studies, education, health policy, or special technologies and
methodologies.
PRESENTATION FORMAT: Authors may indicate their preference for podium or
poster presentation on the submission form, however, the final decision of assignment to
podium or poster presentation will be determined by the Abstract Review Committee.
ACKNOWLEDGMENT: All abstract submitters will receive notification of receipt
from the XULA 2020 Conference Organizers within 30 minutes of submission. Acceptance
notifications will be sent no later than Monday, February 17, 2020. All notifications
regarding abstract submissions will be made via email from xula@the1joshuagroup.com.
SUBMISSION REQUIREMENTS: Please submit abstracts via the online form.
Last Modified: October 3, 2019 2:12 PM Page 2 of 17
ABSTR ACT SUBMISSION ETIQUET TE
DOs DON’Ts &
33 Limit your word count to 300
(not including title, authors,
affiliations, or mention of grant
22 Do not use tables, charts or formulas.
22 Do not include references or credits.
support). 22 Do not add space between
paragraphs.
33 Single space all typing.
22 Do not submit abstracts of published
33 Define all abbreviations the first
papers.
time they appear in the abstract.
22 Do not submit your abstract
33 Proofread the abstract carefully
more than once; all subsequent
before submitting. No corrections
submissions of the same abstract are
will be allowed, and accepted
marked automatically as duplicates
abstracts will be printed in
and removed from the review
conference materials as submitted
process.
and approved by the Abstract Review
Committee.
Last Modified: October 3, 2019 2:12 PM Page 3 of 17ABSTR ACT SUBMISSION FORMAT
All RESEARCH abstracts should be organized using the following format:
TITLE (uppercase)
• Title must be a maximum of 60 characters, spaces and punctuation included.
AUTHORS (mixed cases)
• List those who have significantly contributed to the work should be listed. The recommended
limit is 10 authors.
• The presenting author must be listed first (uppercase letters).
• For each author, include the first and second initials with the last name. Separate authors with a
semicolon.
• Example: FC JONES; AF Hill; KG Witherspoon
AFFILIATIONS (capitalized)
• List institution(s) where work was performed. Include author initials after the corresponding
affiliation.
• Example: Xavier University (FCJ); New Way Out Ministries (AFH, KGW)
PURPOSE (header in uppercase)
• Explain the importance of the research or activity to include objectives, goals, and purpose.
DESIGN METHODS (header in uppercase)
• Briefly explain the procedure and strategy used to gather the information presented.
RESULTS / EXPECTED RESULTS (header in uppercase)
• What did you find when you performed the analysis of the information presented? Remember,
tables and charts are NOT allowed in your submission.
DISCUSSION / CONCLUSION (header in uppercase)
• How does the result address the hypothesis?
• How do the reported findings contribute to the knowledge in the respective field?
GRANT SUPPORT (list only in the grant support field)
• Authors are encouraged to acknowledge grant support for work where applicable.
Last Modified: October 3, 2019 2:12 PM Page 4 of 17ABSTR ACT SUBMISSION FORMAT
All POLICY abstracts must be organized using the following format:
TITLE (uppercase)
• Title must be a maximum of 60 characters, spaces and punctuation included.
AUTHORS (mixed cases)
• List those who have significantly contributed to the work should be listed. The recommended
limit is 10 authors.
• The presenting author must be listed first (uppercase letters).
• For each author, include the first and second initials with the last name. Separate authors with a
semicolon.
• Example: FC JONES; AF Hill; KG Witherspoon
AFFILIATIONS (capitalized)
• List institution(s) where work was performed. Include author initials after the corresponding
affiliation.
• Example: Xavier University (FCJ); New Way Out Ministries (AFH, KGW)
PROBLEM / ISSUE TO BE CONSIDERED (header in uppercase)
UNDERLYING ISSUE KEY FACTORS (header in uppercase)
RECOMMENDATIONS (header in uppercase)
GRANT SUPPORT (list only in the grant support field)
• Authors are encouraged to acknowledge grant support for work where applicable.
Note: Policy/special technologies & methodologies abstracts should contain a brief
description of the problem/issue to be considered, the key factors underlying the issue, and
the recommendations for moving forward.
Last Modified: October 3, 2019 2:12 PM Page 5 of 17ABSTR ACT SUBMISSION FORMAT
All CLINICAL PRACTICE abstracts should be organized using the following
format:
TITLE (uppercase)
• Title must be a maximum of 60 characters, spaces and punctuation included.
AUTHORS (mixed cases)
• List those who have significantly contributed to the work should be listed. The recommended
limit is 10 authors.
• The presenting author must be listed first (uppercase letters).
• For each author, include the first and second initials with the last name. Separate authors with a
semicolon.
• Example: FC JONES; AF Hill; KG Witherspoon
AFFILIATIONS (capitalized)
• List institution(s) where work was performed. Include author initials after the corresponding
affiliation.
• Example: Xavier University (FCJ); New Way Out Ministries (AFH, KGW)
PURPOSE (header in uppercase)
• Explain the importance of the research or activity to include objectives, goals, and purpose.
PROJECT DESCRIPTION (header in uppercase)
• Describe the problem/issue to be considered, the key factors underlying the issue.
• Disclose the best practice guidelines used to address the problem/issue and protocols used to
incorporate these guidelines into practice.
• Note the implications and recommendations for clinical practice moving forward.
GRANT SUPPORT (list only in the grant support field)
• Authors are encouraged to acknowledge grant support for work where applicable.
Last Modified: October 3, 2019 2:12 PM Page 6 of 17ABSTR ACT SUBMISSION GR ADING CRITERIA All abstracts will be reviewed using the following categories: RELEVANCE AND ADHERENCE to the mission of Xavier University of Louisiana College of Pharmacy: to prepare pharmacists to impact medically under-served communities in an effort to eliminate health disparities through patient-centered care, community service, and scholarly work. INNOVATION AND CONTRIBUTION to knowledge base. Discussion of empirical studies, or detailed predictions of the expected direction if the study has not yet been carried out. Are the results likely to be of value to the field? CLARITY AND COMPLETENESS of the content including overall quality, purpose and objective, theoretical and/or applied focus, research/activity methods, findings, and potential practical application. Organization of the abstract content, as outlined on pages 4–6. RESEARCH DESIGN — sufficient background information and description of the data collection and analysis procedures (if applicable). Last Modified: October 3, 2019 2:12 PM Page 7 of 17
ABSTR ACT SUBMISSION CHECKLIST
The following items must be completed for successful submissions
and presentations:
FF REGISTER to attend the XULA 2020 Conference. The Early Bird Registration Discount expires
at 11:59 PM Central on Monday, December 16, 2019, and the Standard Registration Rate expires at
11:59 PM Central on Monday, March 2, 2020. All registration fees must be paid by the respective
deadlines in order for discounts to apply.
FF PREPARE YOUR ABSTRACT according to the guidelines (remember not to exceed
300 words).
FF SUBMIT YOUR ABSTRACT via the online form by 11:59 PM Central on Monday,
February 10, 2020 via the online form.
FF ACKNOWLEDGMENT OF RECEIPT will come from the Conference Organizer
(xula@the1joshuagroup.com) within 30 minutes of submission. If you have not received an email
receipt (remember to check your junk mail folder), please call (404) 559-6191.
FF ABSTRACTS SELECTED for podium and/or poster presentation will receive notification
emails no later than Monday, February 17, 2020.
FF CONFIRM YOUR PARTICIPATION as an abstract presenter using the link in your
notification email no later than Monday, March 2, 2020. If you submit more than one abstract,
then you must confirm for each accepted abstract that you plan to present at the conference.
For inquiries, please contact:
XULA-COP Conference Organizer
c/o 1Joshua Group, LLC
1513 East Cleveland Avenue
BLDG 100-B, STE 202
Atlanta, GA 30344-6947
Phone: (404) 559-6191
Fax: (404) 559-6198
Email: xula@the1JG.com
Last Modified: October 3, 2019 2:12 PM Page 8 of 17to
POSTER PRESENTATIONS ON-SITE
NEED KNOW
Poster presentations will occur during Poster Sessions March 25–26, 2020.
By now, you should have received specifics on installation, presentation, and dismantle
times. Poster presenters must register to attend the XULA 2019 Conference.
POSTER SIZE: An 8’x4’ poster board will be furnished for all participants to display their
posters. The mounting surface area is 7’10” wide by 3’10” tall, do not exceed this dimension.
SET-UP & DISMANTLE: The presenting author is responsible for displaying the poster
at the beginning of the assigned poster session and removing it at the end of the assigned
poster session, at times to be designated in the Poster Acceptance Package. Please bring
your own push pins to mount your poster. Detailed instructions for poster displays, poster
number, and location will also be included in the Poster Acceptance Package.
PRESENTING AUTHORS: The presenting author must be available at the poster
display during designated Poster Session. Conference participants will be invited to speak
with authors either one-on-one format or in group sessions. There will be no audio-visual
equipment for poster presentations, as space does not permit.
Last Modified: October 3, 2019 2:12 PM Page 9 of 17DEVELOPING YOUR POSTER FOR PRESENTATION
1 2 3
LAYOUT: Organize your poster from left to right and top to bottom. One good method is to
divide your material into 3 to 5 logical sections. Lay out each section as a vertical module on your
poster, moving from left to right and leaving space between each module. White (empty) space
is important and can be used to separate parts of your poster or establish relationships between
modules or sections. Avoid clutter.
GRAPHS AND TABLES: As with the rest of your poster, strive for brevity, simplicity, and clarity.
Here are some rules of thumb. Tables with more than 20 data cells will begin to overwhelm a typical
viewer. Similarly, graphs with no more than three lines or six bars are preferable. Include captions
and legends but keep them short and informative. Maintain a consistent labeling system for all
graphs. When data of the same type are presented on separate graphs, it may be useful to use the
same scale on all axes.
Last Modified: October 3, 2019 2:12 PM Page 10 of 17DEVELOPING YOUR POSTER FOR PRESENTATION
TYPE STYLE: To maintain legibility avoid the use of ornate or script fonts. Blocky fonts like Swiss,
Helvetica and Arial or conservative serif types like Times Roman and Bookman read well. In the
body of the text, follow normal convention when employing italics and capital letters.
TYPE SIZE: All text must be legible. The title should be legible from at least 16 feet and text from
3-5 feet. Minimum recommended font sizes are summarized below:
Title 90
Heading 60
Subheading 30
Text 18
Last Modified: October 3, 2019 2:12 PM Page 11 of 17DEVELOPING YOUR POSTER FOR PRESENTATION
BACKGROUND: Elaborate background images call attention to the background—not your
science. Images and patterns will cause your material to be very difficult to read and visually
obscured. However conventional it may be, choose a background that accentuates the material
you want to present.
COLORS: Do not use fluorescent or intense colors. Colors used on graphs should consistently
represent the same population or variable throughout. Subdued or neutral colors toned down with
gray are best for backgrounds and large areas. Blues, browns, greens, or grays are appropriate for
framing. Background for text and graphs can be white, but off -white or beige is easier on the eyes.
22 Antota isque sequo
doluptas volume dis
nostium faceate quis
officipsus, endellam
dignien tiusam
sitibusapit, ute plibus
plias ratur aut lab int
autecer fererior saesto
tore nonserum, invel
33
Aque liquisi ipsundi
doluptur? Ciani volles
maximporiam, siti
esequun dipsam, cone
suntis am eosandigeni
quamusdant,
commodipsa dolum
con eos et, temporum
sum accae reius ea
assima doluptatio. et omniendi blatur as modiat et laboribus dusam, am quid que consed que la quiscii vendiscil id ut dest el
Nequi occulli tatur, dollat. autecto inci optae entiur, sam antem as simusanditem fugitat il in rerunte mporita
simodi blam labor ped quam estiatur res rehendi dolorrum iustia secus, te nihil temolestrum quaeped
Pudi nonse verchitis
sitem fugiati officiis asi qui ne accullo cus restet, aborendi erestisquis dem rae minciundio. Itaestio
consequ iaeptat
net harchil isquas es riatur mos dolor reri aliquo beatem illabor eptat. tectibus cus, sum
iberum et posam iur as
quam earis volor alitio doloren imenectinus exeruntis is es ut fugiam fuga. Pa vendis
atus, sunt dendiorest Em evelit praes alitem
ipienectur sequam evelluptat. expliquisci ilibus. intiatem. Ut haribus
plandi dolupture pel unto berum as et
labor sequi ad qui ullabor sed.
int acia doluptaepe Ut exerchictas ipiet pore cusam,
22 33
Last Modified: October 3, 2019 2:12 PM Page 12 of 17to
PODIUM PRESENTATIONS ON-SITE
NEED KNOW
Podium presentations will occur during concurrent podium sessions in
the 2020 conference. Upon acceptance, each podium presenter will be provided with
specifics on the assigned session. Podium presenters must register to attend the XULA
2020 Conference.
PRESENTATION LENGTH: Make note that abstracts selected for podium presentation
will be allowed a maximum of 5–10 slides for a 15-minute presentation, not including the
Questions & Answers period.
SUBMIT SLIDES: Slide presentations must be submitted in widescreen (16:9)
PowerPoint format to the Conference Organizer, 1Joshua Group, via email
(xula@the1joshuagroup.com) no later than Monday, March 16, 2020; presentations files
will not be accepted on-site.
Last Modified: October 3, 2019 2:12 PM Page 13 of 17DEVELOPING YOUR PODIUM PRESENTATION
PROOFREAD EVERYTHING, including visuals and numbers.
USE KEY PHRASES about your topic. Seasoned presenters use key phrases and include only
essential information. Choose only the top three or four points about your topic and make them
consistently throughout the delivery.
MAKE YOUR SLIDES EASY TO FOLLOW. Put the title at the top of the slide where your
audience expects to find it. Keep important information near the top. Oftentimes, the bottom
portions of slides cannot be seen by viewers in the back rows, because heads are in the way. Limit
the number of words on the screen. Try not to use more than three bullets per slide. Don’t overload
your slides with too much text or data. The surrounding white space will make it easier to read.
LIMIT PUNCTUATION and avoid all capital letters. Punctuation can needlessly clutter the
slide and the use of all caps makes statements more difficult to read and is like SHOUTING at
your audience.
22 33
Oviti conserum qui corenihicid qui optaest iumquides resed Et ped qui dolum
moleseq uaecum adistrum velibus res volendis es qui des
venda quas et optatiat. Dit aut porepel et elessunti dolupta • Nonsedi gendandias restiae
turepedis dolorum, cor magnisquia doloribus aut ium eum,
none vit volor aut voles eatum vendam a quia voluptatatem • Aquae rem endebis ero
voluptaero essuntisque num sitatur? • Imoloreheni ab ipsanti
Last Modified: October 3, 2019 2:12 PM Page 14 of 17DEVELOPING YOUR PODIUM PRESENTATION
AVOID FANCY FONTS. Choose a font that is simple and easy to read. Avoid script type fonts
as they are hard to read on screen. Use, at most, two different fonts – perhaps one for headings and
another for content. Keep all fonts large enough (at least 24 pt and preferably 30 pt) so that people
at the back of the room will be able to easily read what is on the screen.
USE CONTRASTING COLORS for text and background. Avoid the use of patterned and/
or textured backgrounds as they distract from the presentation and reduce the readability of
text. Placing dark text on a light background is best; tone down the potential glare of a white
background by using beige or another light color. Note: colors appear lighter when projected and
pale colors often appear as white. A dark background with white font reduces glare. When using a
dark background, be sure to make text a light color for easy reading.
22Et ped qui dolum ne accupta nonse 33Et ped qui dolum
Oviti conserum qui corenihicid qui optaest iumquides resed
moleseq uaecum adistrum velibus res volendis es qui des Oviti conserum
venda quas et optatiat. Corenihicid qui optaest
Dit aut porepel et elessunti dolupta turepedis dolorum, cor iumquides resed velibus
magnisquia doloribus aut ium eum, none vit volor aut voles venda quas.
eatum vendam a quia voluptatatem voluptaero essuntisque
num sitatur?
Last Modified: October 3, 2019 2:12 PM Page 15 of 17DEVELOPING YOUR PODIUM PRESENTATION
LIMIT THE NUMBER OF SLIDES. Keeping the number of slides to a minimum ensures that
the presentation will not become too long and drawn out. It also avoids the problem of continually
changing slides during the presentation which can be a distraction to your audience. If the
audience is reading slides, they are not paying attention to you. A more successful and engaging
presentation is one that averages about one slide per minute or even one slide every two minutes.
USE PHOTOS, CHARTS AND GRAPHS. Combining photos, charts, and graphs will add
variety and keep your audience interested in the presentation. Avoid having text only slides.
22Et ped qui dolum ne accupta nonse 3Et3 ped qui dolum
Oviti conserum qui corenihicid qui optaest iumquides resed
moleseq uaecum adistrum velibus res volendis es qui des
Nonsedi
venda quas et optatiat.
Ggendandias
Dit aut porepel et elessunti dolupta turepedis dolorum, cor Nam inihilit
magnisquia doloribus aut ium eum, none vit volor aut voles Que parchic
eatum vendam a quia voluptatatem voluptaero essuntisque
num sitatur?
Last Modified: October 3, 2019 2:12 PM Page 16 of 17FINAL NOTES FOR POSTER & PODIUM PRESENTATION
Please keep the following dates in mind when planning to attend and present an abstract during
the XULA 2020 Conference:
Monday, 03/02/2020 : : Notification Responses Due
Authors notified of acceptance must complete the response form before 03/03/2020.
Monday, 03/02/2020 : : Standard Registration Rate Ends
Late / On-site registration rates will apply beginning 03/03/2020.
Monday, 03/02/2020 : : Lodging Discount Deadline
Lodging at the Sheraton New Orleans Hotel is based on availability.
Monday, 03/16/2020 : : Podium Presentation files Due
All files must be submitted in PowerPoint wide screen (16:9) format.
Wednesday, 03/25/2020 : : Conference Begins
The Opening Plenary Session begins at 12:00 PM Central.
For all inquiries, contact the Conference Organizer:
1Joshua Group, LLC
1513 East Cleveland Avenue
BLDG 100-B, STE 202
Atlanta, GA 30344-6947
404.559.6191
XULA@the1JG.com
Last Modified: October 3, 2019 2:12 PM Page 17 of 17You can also read
